Cardiac	cardiac	O	O
transplantation	transplantation	O	O
:	:	O	O
improved	improved	O	O
quality	quality	O	O
of	of	O	O
survival	survival	O	O
with	with	O	O
a	a	O	O
modified	modified	O	O
immunosuppressive	immunosuppressive	O	O
protocol	protocol	O	O
.	.	O	O

The	the	O	O
effects	effects	O	O
on	on	O	O
renal	renal	O	O
function	function	O	O
on	on	O	O
two	two	O	O
different	different	O	O
immunosuppressive	immunosuppressive	O	O
protocols	protocols	O	O
were	were	O	O
evaluated	evaluated	O	O
retrospectively	retrospectively	O	O
in	in	O	O
two	two	O	O
subsequent	subsequent	O	O
groups	groups	O	O
of	of	O	O
heart	heart	O	O
transplant	transplant	O	O
recipients	recipients	O	O
.	.	O	O

In	in	O	O
group	group	B_chemicals	B_disease
I	i	I_chemicals	I_disease
,	,	O	O
cyclosporine	cyclosporine	S_chemicals	O
was	was	O	O
given	given	O	O
before	before	O	O
the	the	O	O
procedure	procedure	O	O
at	at	O	O
a	a	O	O
loading	loading	O	O
dose	dose	O	O
of	of	O	O
17.5	17.5	O	O
mg/kg	mg/kg	O	O
and	and	O	O
then	then	O	O
continued	continued	O	O
after	after	O	O
the	the	O	O
procedure	procedure	O	O
to	to	O	O
keep	keep	O	O
a	a	O	O
whole	whole	O	O
blood	blood	O	O
level	level	O	O
about	about	O	O
1000	1000	O	O
ng/ml	ng/ml	O	O
.	.	O	O

In	in	O	O
group	group	B_chemicals	B_disease
II	ii	I_chemicals	I_disease
,	,	O	O
cyclosporine	cyclosporine	S_chemicals	O
was	was	O	O
started	started	O	O
only	only	O	O
after	after	O	O
the	the	O	O
procedure	procedure	O	O
at	at	O	O
a	a	O	O
lower	lower	O	O
dosage	dosage	O	O
and	and	O	O
was	was	O	O
complemented	complemented	O	O
by	by	O	O
azathioprine	azathioprine	S_chemicals	O
,	,	O	O
which	which	O	O
was	was	O	O
used	used	O	O
for	for	O	O
the	the	O	O
first	first	O	O
postoperative	postoperative	O	O
week	week	O	O
.	.	O	O

Group	group	B_chemicals	B_disease
II	ii	I_chemicals	I_disease
showed	showed	O	O
a	a	O	O
better	better	O	O
perioperative	perioperative	O	O
renal	renal	O	O
function	function	O	O
as	as	O	O
determined	determined	O	O
by	by	O	O
serum	serum	O	O
blood	blood	O	O
urea	urea	S_chemicals	O
nitrogen	nitrogen	O	O
and	and	O	O
serum	serum	O	O
creatinine	creatinine	S_chemicals	O
levels	levels	O	O
.	.	O	O

Group	group	B_chemicals	B_disease
II	ii	I_chemicals	I_disease
also	also	O	O
showed	showed	O	O
a	a	O	O
significant	significant	O	O
decrease	decrease	O	O
of	of	O	O
chronic	chronic	O	O
nephrotoxicity	nephrotoxicity	O	O
secondary	secondary	O	O
to	to	O	O
long-term	long-term	O	O
therapy	therapy	O	O
with	with	O	O
cyclosporine	cyclosporine	S_chemicals	O
.	.	O	O

Despite	despite	O	O
this	this	O	O
improvement	improvement	O	O
in	in	O	O
late	late	O	O
renal	renal	O	O
function	function	O	O
,	,	O	O
group	group	B_chemicals	B_disease
II	ii	I_chemicals	I_disease
still	still	O	O
shows	shows	O	O
a	a	O	O
slow	slow	O	O
rise	rise	O	O
in	in	O	O
serum	serum	O	O
creatinine	creatinine	S_chemicals	O
.	.	O	O

We	we	O	O
think	think	O	O
that	that	O	O
even	even	O	O
these	these	O	O
lower	lower	O	O
dosages	dosages	O	O
of	of	O	O
cyclosporine	cyclosporine	S_chemicals	O
can	can	O	O
cause	cause	O	O
chronic	chronic	O	O
nephrotoxicity	nephrotoxicity	O	O
and	and	O	O
that	that	O	O
further	further	O	O
modification	modification	O	O
of	of	O	O
the	the	O	O
immunosuppressive	immunosuppressive	O	O
regimen	regimen	O	O
is	is	O	O
required	required	O	O
to	to	O	O
completely	completely	O	O
abolish	abolish	O	O
this	this	O	O
toxic	toxic	O	O
side	side	O	B_disease
effect	effect	O	I_disease
.	.	O	O

